TP53 and neoplasm: We found that Isg15 depletion enhances the Nutlin-3-mediated p53 activation in cancer cells (Figure 5D) and Isg15 deficient mice developed less lesions in the lung in a kRas mouse tumor model (Figure 5A&B).